BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ERG, P11308, 2078
30 results:

  • 1. PBX1, EMCN and erg are associated with the sub-clusters and the prognosis of VHL mutant clear cell renal cell carcinoma.
    Wang H; Wang X; Xu L; Zhang J
    Sci Rep; 2022 May; 12(1):8955. PubMed ID: 35624190
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma.
    Canete-Portillo S; Rodriguez Pena MDC; Wang D; Sanchez DF; Netto GJ; Magi-Galluzzi C
    Virchows Arch; 2021 Dec; 479(6):1187-1196. PubMed ID: 34611731
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
    Liu D; Augello MA; Grbesa I; Prandi D; Liu Y; Shoag JE; Karnes RJ; Trock BJ; Klein EA; Den RB; Demichelis F; Davicioni E; Sboner A; Barbieri CE
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998599
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Is hypervascular papillary renal cell carcinoma present?
    Yamamoto T; Gulanbar A; Hayashi K; Kohno A; Komai Y; Yonese J; Matsueda K; Inamura K
    Abdom Radiol (NY); 2021 Apr; 46(4):1687-1693. PubMed ID: 33047228
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targetable gene fusions and aberrations in genitourinary oncology.
    Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
    Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
    Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR
    Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Anastomosing Hemangioma Incidentally Found in kidney or Adrenal Gland: Study of 10 Cases and Review of Literature.
    Zhou J; Yang X; Zhou L; Zhao M; Wang C
    Urol J; 2020 Apr; 17(6):650-656. PubMed ID: 32281091
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer.
    Zhu X; Tan J; Liang Z; Zhou M
    Medicine (Baltimore); 2019 Jul; 98(30):e16672. PubMed ID: 31348324
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.
    Berglund AE; Rounbehler RJ; Gerke T; Awasthi S; Cheng CH; Takhar M; Davicioni E; Alshalalfa M; Erho N; Klein EA; Freedland SJ; Ross AE; Schaeffer EM; Trock BJ; Den RB; Cleveland JL; Park JY; Dhillon J; Yamoah K
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):292-302. PubMed ID: 30367117
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Unclassified hemangioma-like renal cell carcinoma: a potential diagnostic pitfall.
    Taneja K; Arora S; Rogers CG; Gupta NS; Cheng L; Williamson SR
    Hum Pathol; 2018 May; 75():132-136. PubMed ID: 29104112
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Intrafocal heterogeneity of erg protein expression and gene fusion pattern in prostate cancer.
    Suh JH; Park JH; Lee C; Moon KC
    Prostate; 2017 Oct; 77(14):1438-1445. PubMed ID: 28845585
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine.
    Pellegrini KL; Patil D; Douglas KJS; Lee G; Wehrmeyer K; Torlak M; Clark J; Cooper CS; Moreno CS; Sanda MG
    Prostate; 2017 Jun; 77(9):990-999. PubMed ID: 28419548
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies.
    Alikhan MB; Pease G; Watkin W; Grogan R; Krausz T; Antic T
    Hum Pathol; 2017 Mar; 61():158-163. PubMed ID: 27769872
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
    Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
    Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Frequency of PTEN alterations, TMPRSS2-erg fusion and their association in prostate cancer.
    Fallahabadi ZR; Noori Daloii MR; Mahdian R; Behjati F; Shokrgozar MA; Abolhasani M; Asgari M; Shahrokh H
    Gene; 2016 Jan; 575(2 Pt 3):755-60. PubMed ID: 26424596
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The TMPRSS2-erg Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition.
    Chatterjee P; Choudhary GS; Alswillah T; Xiong X; Heston WD; Magi-Galluzzi C; Zhang J; Klein EA; Almasan A
    Mol Cancer Ther; 2015 Aug; 14(8):1896-906. PubMed ID: 26026052
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
    Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY
    Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunoreactivity using anti-erg monoclonal antibodies in sarcomas is influenced by clone selection.
    Machado I; Mayordomo-Aranda E; Scotlandi K; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2014 Aug; 210(8):508-13. PubMed ID: 24906228
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Aberrant expression of neuroendocrine markers in angiosarcoma: a potential diagnostic pitfall.
    Tessier Cloutier B; Costa FD; Tazelaar HD; Folpe AL
    Hum Pathol; 2014 Aug; 45(8):1618-24. PubMed ID: 24846674
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
    Wittström E; Nordling M; Andréasson S
    Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.